Friday, February 18, 2005
  WSJ.com - U.S. Home WSJ.com - U.S. HomeFDA ADVISERS narrowly recommended that Merck's Vioxx be allowed back on the market, despite the risk of heart trouble. They also said Pfizer painkillers Celebrex and Bextra should remain available. Merck shares soared 13%. 6:51 p.m.


MORE....  6:23 PM
Comments: Post a Comment

<< Home
Vioxx Lawyer Information about Vioxx litigation and other legal topics related to pharmaceutical legal and personal injury topics.

Vioxx Information and Legal Info
Injury Lawyer and Criminal Lawyer Articles
ARCHIVES
Friday, December 31, 2004 / Saturday, January 01, 2005 / Sunday, January 02, 2005 / Monday, January 03, 2005 / Monday, January 17, 2005 / Saturday, January 22, 2005 / Sunday, January 23, 2005 / Monday, January 24, 2005 / Friday, January 28, 2005 / Saturday, January 29, 2005 / Sunday, January 30, 2005 / Monday, January 31, 2005 / Thursday, February 03, 2005 / Friday, February 04, 2005 / Saturday, February 05, 2005 / Sunday, February 06, 2005 / Monday, February 07, 2005 / Tuesday, February 08, 2005 / Wednesday, February 09, 2005 / Thursday, February 10, 2005 / Friday, February 11, 2005 / Saturday, February 12, 2005 / Monday, February 14, 2005 / Tuesday, February 15, 2005 / Wednesday, February 16, 2005 / Thursday, February 17, 2005 / Friday, February 18, 2005 / Saturday, February 19, 2005 / Sunday, February 20, 2005 / Monday, February 21, 2005 / Tuesday, February 22, 2005 / Thursday, February 24, 2005 / Monday, February 28, 2005 /


Powered by Blogger